[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christine M. Lovly<\/i><\/u><\/presenter>. Vanderbilt University School of Medicine, Nashville, TN","CSlideId":"","ControlKey":"06847f6c-3585-421a-a142-2fb201744231","ControlNumber":"110","DisclosureBlock":"&nbsp;<b>&nbsp;C.M. Lovly:<\/b>  ; Amgen. ; Amgen. ; Amgen. ; Arrivent. ; Arrivent. ; Arrivent. ; AstraZeneca. ; AstraZeneca. ; AstraZeneca. ; Blueprints Medicine. ; Blueprints Medicine. ; Blueprints Medicine. ; Cepheid. ; Cepheid. ; Cepheid. ; D2G Therapeutics. ; D2G Therapeutics. ; D2G Therapeutics. ; Daiichi Sankyo Company. ; Daiichi Sankyo Company. ; Daiichi Sankyo Company. ; EMD Serono, Inc.. ; EMD Serono, Inc.. ; EMD Serono, Inc.. ; Eli Lilly and Company. ; Eli Lilly and Company. ; Eli Lilly and Company. ; F. Hoffmann-La Roche. ; F. Hoffmann-La Roche. ; F. Hoffmann-La Roche. ; Foundation Medicine, Inc.. ; Foundation Medicine, Inc.. ; Foundation Medicine, Inc.. ; Genentech. ; Genentech. ; Genentech. ; Genentech USA, Inc.. ; Genentech USA, Inc.. ; Genentech USA, Inc.. ; Janssen Biotech. ; Janssen Biotech. ; Janssen Biotech. ; Janssen Biotech, Inc.. ; Janssen Biotech, Inc.. ; Janssen Biotech, Inc.. ; Medscape. ; Medscape. ; Medscape. ; Novartis Foundation. ; Novartis Foundation. ; Novartis Foundation. ; PFIZER CANADA INC. ; PFIZER CANADA INC. ; PFIZER CANADA INC. ; Puma Biotechnology, Inc.. ; Puma Biotechnology, Inc.. ; Puma Biotechnology, Inc.. ; Syros. ; Syros. ; Syros. ; Takeda Oncology. ; Takeda Oncology. ; Takeda Oncology.","End":"4\/19\/2023 10:16:00 AM","HasWebcast":null,"Highlights":[],"Id":"108","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Christine Lovly, MD;PhD","PresenterKey":"2ef6f914-caef-428d-9c4e-780e91cce41a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 10:15:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christine M. Lovly<\/i><\/u><\/presenter>. Vanderbilt University Medical Center, Nashville, TN","CSlideId":"","ControlKey":"56f9212c-e26e-4488-9333-f37a7790ead4","ControlNumber":"10362","DisclosureBlock":"<b>&nbsp;C. M. Lovly, <\/b> <br><b>Amgen<\/b> I, I, I. <br><b>Arrivent<\/b> I, I, I. <br><b>AstraZeneca<\/b> I, I, I. <br><b>Blueprints Medicine<\/b> I, I, I. <br><b>Cepheid<\/b> I, I, I. <br><b>D2G Therapeutics<\/b> I, I, I. <br><b>Daiichi Sankyo Company<\/b> I, I, I. <br><b>EMD Serono, Inc.<\/b> I, I, I. <br><b>Eli Lilly and Company<\/b> I, I, I. <br><b>F. Hoffmann-La Roche<\/b> I, I, I. <br><b>Foundation Medicine, Inc.<\/b> I, I, I. <br><b>Genentech<\/b> I, I, I. <br><b>Genentech USA, Inc.<\/b> I, I, I. <br><b>Janssen Biotech<\/b> I, I, I. <br><b>Janssen Biotech, Inc.<\/b> I, I, I. <br><b>Medscape<\/b> I, I, I. <br><b>Novartis Foundation<\/b> I, I, I. <br><b>PFIZER CANADA INC<\/b> I, I, I. <br><b>Puma Biotechnology, Inc.<\/b> I, I, I. <br><b>Syros<\/b> I, I, I. <br><b>Takeda Oncology<\/b> I, I, I.","End":"4\/19\/2023 10:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"9138","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Christine Lovly, MD;PhD","PresenterKey":"2ef6f914-caef-428d-9c4e-780e91cce41a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 10:15:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christine M. Lovly<\/i><\/u><\/presenter>. Vanderbilt University Medical Center, Nashville, TN","CSlideId":"","ControlKey":"5358f717-1faa-4b38-8410-0fbe5c945519","ControlNumber":"8413","DisclosureBlock":"<b>&nbsp;C. M. Lovly, <\/b> <br><b>Amgen<\/b> I, I, I. <br><b>Arrivent<\/b> I, I, I. <br><b>AstraZeneca<\/b> I, I, I. <br><b>Blueprints Medicine<\/b> I, I, I. <br><b>Cepheid<\/b> I, I, I. <br><b>D2G Therapeutics<\/b> I, I, I. <br><b>Daiichi Sankyo Company<\/b> I, I, I. <br><b>EMD Serono, Inc.<\/b> I, I, I. <br><b>Eli Lilly and Company<\/b> I, I, I. <br><b>F. Hoffmann-La Roche<\/b> I, I, I. <br><b>Foundation Medicine, Inc.<\/b> I, I, I. <br><b>Genentech<\/b> I, I, I. <br><b>Genentech USA, Inc.<\/b> I, I, I. <br><b>Janssen Biotech<\/b> I, I, I. <br><b>Janssen Biotech, Inc.<\/b> I, I, I. <br><b>Medscape<\/b> I, I, I. <br><b>Novartis Foundation<\/b> I, I, I. <br><b>PFIZER CANADA INC<\/b> I, I, I. <br><b>Puma Biotechnology, Inc.<\/b> I, I, I. <br><b>Syros<\/b> I, I, I. <br><b>Takeda Oncology<\/b> I, I, I.","End":"4\/19\/2023 10:40:00 AM","HasWebcast":null,"Highlights":[],"Id":"934","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Christine Lovly, MD;PhD","PresenterKey":"2ef6f914-caef-428d-9c4e-780e91cce41a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Novel paradigms for oncogene directed therapies for NSCLC","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 10:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Novel paradigms for oncogene directed therapies for NSCLC","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"7ecf63d9-77ae-42bd-a341-0436172662a7","ControlNumber":"8416","DisclosureBlock":"","End":"4\/19\/2023 10:45:00 AM","HasWebcast":null,"Highlights":[],"Id":"937","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 10:40:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Ferdinandos Skoulidis<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"7e23d846-9af2-4912-b78c-ef475c9e2b0e","ControlNumber":"363","DisclosureBlock":"<b>&nbsp;F. Skoulidis, <\/b> <br><b>Amgen<\/b> I. <br><b>Amgen Inc.<\/b> I, G, T. <br><b>AstraZeneca<\/b> I. <br><b>BergenBio<\/b> I. <br><b>Dava Oncology<\/b> I, T. <br><b>Guardant Health Inc<\/b> I. <br><b>IDEOlogy Health<\/b> T. <br><b>Intellisphere LLC<\/b> I. <br><b>MECC<\/b> I. <br><b>Medscape<\/b> I. <br><b>Merck<\/b> G. <br><b>Mirati Therapeutics<\/b> G. <br><b>NavirePharma<\/b> I. <br><b>Novartis<\/b> I. <br><b>PFIZER PHARMA GMBH<\/b> G. <br><b>Physicians' education Resource. LLC<\/b> I. <br><b>Revolution Medicines<\/b> G. <br><b>Tango Therapeutics<\/b> I. <br><b>VSPO McGill Universite de Montreal<\/b> I.","End":"4\/19\/2023 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"224","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Ferdinandos Skoulidis, MD;PhD","PresenterKey":"56f3813b-0283-4f25-8ca0-b3c350940edc","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Emerging therapeutic strategies for KRAS-mutant NSCLC","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 11:10:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Emerging therapeutic strategies for KRAS-mutant NSCLC","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"a5c2c679-8eff-435e-95eb-98b1ca356949","ControlNumber":"8417","DisclosureBlock":"","End":"4\/19\/2023 11:10:00 AM","HasWebcast":null,"Highlights":[],"Id":"938","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 11:05:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Purushothama Rao Tata<\/i><\/u><\/presenter>. Duke University, Durham, NC","CSlideId":"","ControlKey":"3e769cae-c26e-40c2-ab85-66a2907a8695","ControlNumber":"362","DisclosureBlock":"<b>&nbsp;P. R. Tata, <\/b> <br><b>Boehringer Ingelheim<\/b> I. <br><b>Cellarity Inc.<\/b> I. <br><b>Genentech<\/b> I. <br><b>Iolux Inc.<\/b> O. <br><b>Surrozen Inc<\/b> I. <br><b>Patent<\/b> P.","End":"4\/19\/2023 11:05:00 AM","HasWebcast":null,"Highlights":[],"Id":"223","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Purushothama Tata, PhD","PresenterKey":"4cdcf51e-8ca6-478d-a971-b5d5f3967820","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Defining cells and cell states in non-small cell lung cancers","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 10:45:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Defining cells and cell states in non-small cell lung cancers","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"7d309945-1104-46f0-a15c-e3068ecc97a5","ControlNumber":"8418","DisclosureBlock":"","End":"4\/19\/2023 11:35:00 AM","HasWebcast":null,"Highlights":[],"Id":"939","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 11:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"203e7c20-7526-4bf4-b349-3bcc6f0aa6e9","ControlNumber":"8419","DisclosureBlock":"","End":"4\/19\/2023 11:45:00 AM","HasWebcast":null,"Highlights":[],"Id":"940","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panel Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 19 2023 10:15AM","SessionId":"78","SessionOnDemand":"False","SessionTitle":"Dharma Master Jiantai Advances in Lung Cancer Research Session: Advances in NSCLC - More Targets, More Drugs, and More Cell States to Consider","ShowChatLink":"false","Start":"4\/19\/2023 11:35:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panel Discussion","Topics":null,"cSlideId":""}]